Net Loss of Astec Lifesciences reported to Rs 38.56 crore in the quarter ended September 2024 as against net loss of Rs 13.43 crore during the previous quarter ended September 2023. Sales declined 11.05% to Rs 98.55 crore in the quarter ended September 2024 as against Rs 110.79 crore during the previous quarter ended September 2023. ParticularsQuarter EndedSep. 2024Sep. 2023% Var. Sales98.55110.79 -11 OPM %-20.03-3.09 - PBDT-27.07-8.44 -221 PBT-38.54-17.60 -119 NP-38.56-13.43 -187 Powered by Capital Market - Live News

Astec Lifesciences will hold a meeting of the Board of Directors of the Company on 25 October 2024Powered by Capital Market - Live News

Astec LifeSciences announced that Dr. Brahma Nand Vyas has tendered his resignation as an �Independent Director� of the Company with effect from closure of business hours on 4 October 2024. Powered by Capital Market - Live News

Astec Lifesciences announced that Anurag Roy has tendered his resignation as the �Whole Time Director & Chief Executive Officer� of the Company with effect from closure of business hours on 25 October 2024.Powered by Capital Market - Live News

Astec Lifesciences has appointed Dr. Ganapati Dadasaheb Yadav as a �Non-Executive & Independent Director� of the Company with effect from 17 September 2024. Powered by Capital Market - Live News